Target
Metallothionein-2
Ligand
BDBM463447
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
0.800±n/a nM
Citation
 Ruch Werneck Guimarães, CFelype Zaneti De Azevedo, HMascarello, AWatanabe Da Costa, RFreire Torres Russo, VMannochio De Souza Russo, E Compounds, process for obtaining the compounds, pharmaceutical composition, use of the compounds and method for treating psychiatric disorders and/or sleep disorders US Patent  US10781182 Publication Date 9/22/2020 
Target
Name:
Metallothionein-2
Synonyms:
CES1 | MT-2 | MT-II | MT2 | MT2A | MT2_HUMAN | Metallothionein-2A | Metallothionein-II
Type:
Protein
Mol. Mass.:
6046.23
Organism:
Human
Description:
P02795
Residue:
61
Sequence:
MDPNCSCAAGDSCTCAGSCKCKECKCTSCKKSCCSCCPVGCAKCAQGCICKGASDKCSCCA
  
Inhibitor
Name:
BDBM463447
Synonyms:
US10781182, Compound IA2-143 | US11091445, Compound code IA2-143
Type:
Small organic molecule
Emp. Form.:
C13H16ClN3O3
Mol. Mass.:
297.737
SMILES:
COc1nc2cc(Cl)c(OC)cc2n1CCNC(C)=O
Structure:
Search PDB for entries with ligand similarity: